# Community-acquired pneumonia - Category: infectious - Review status: reviewed (every claim checked against a document named on this page) - Sources: ATS/IDSA CAP Guideline 2019 · Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) · MSF Essential Drugs 2024 - paracetamol (oral) - Verified date: 2026-08 ## Verified against - ATS/IDSA CAP Guideline 2019 - Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) - MSF Essential Drugs 2024 - paracetamol (oral) - Community-Acquired Pneumonia - disease-level clinical article (community-acquired-pneumonia-clinical.txt) ## Treatment metadata - Amoxicillin — 500 mg — oral.solid - Amoxicillin + Clavulanic acid — 1000 mg — oral.solid - Referral & safety-netting (no drug therapy) - Clarithromycin — 500 mg — oral.solid - Levofloxacin — 500 mg — oral.solid - Doxycycline — 100 mg — oral.solid - Paracetamol — 500 mg — oral.solid ## Complete treatment card ```text COMMUNITY-ACQUIRED PNEUMONIA Sources: ATS/IDSA CAP Guideline 2019 · Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) · MSF Essential Drugs 2024 - paracetamol (oral) Review status: REVIEWED against ATS/IDSA CAP Guideline 2019, Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph), MSF Essential Drugs 2024 - paracetamol (oral), Community-Acquired Pneumonia - disease-level clinical article (community-acquired-pneumonia-clinical.txt) (2026-08) IS IT THIS? - reference only, to read alongside your own examination RED FLAGS (2) - Cardiorespiratory failure or sepsis - refer whatever the score - Cannot take oral medicines SYMPTOMS - what the patient reports (2) - Acute lower respiratory tract symptoms with a clinical diagnosis of pneumonia - NG250 treats the primary-care diagnosis as clinical - Confusion, or new disorientation in person, place or time, is a scored feature and not a detail [confusion] SIGNS - what you find (3) - Respiratory rate 30 or more per minute - Diastolic BP 60 mmHg or below, or systolic under 90 mmHg [hypotension] - Age 65 or over counts towards risk in its own right TESTS (3) - Nothing is needed to score CRB65 - it is bedside - NG250 1.4.3 places baseline CRP at hospital admission, not in the clinic - NG250 1.4.5: do not routinely offer microbiological tests in low-severity disease Score CRB65 - Can this pneumonia be managed at home? Source NICE NG250 Pneumonia: diagnosis and management (2025) Status traced to the source above Rx: Antibiotic | If comorbidity or recent antibiotics | Main treatment | Pain and fever ANTIBIOTIC - choose one 1. AMOXICILLIN [1st line] Adult 500-1000 mg TID x 5-7 days Peds 80-90 mg/kg/day [child max 1000 mg] (Divided BID-TID; targets penicillin-intermediate S. pneumoniae ENDF caps amoxicillin at 500 mg per dose for most indications; at the twice-daily schedule this regimen uses, that is 1,000 mg in a day, which is the ceiling applied to the table above (ENDF Antimicrobial 2023).) 3kg -> 240-270 mg/day 4kg -> 320-360 mg/day 5kg -> 400-450 mg/day 6kg -> 480-540 mg/day 7kg -> 560-630 mg/day 8kg -> 640-720 mg/day 9kg -> 720-810 mg/day 10kg -> 800-900 mg/day 11kg -> 880-990 mg/day 12kg -> 960-1000 mg/day (upper capped) 13kg -> 1000 mg/day (capped) 14kg -> 1000 mg/day (capped) 15kg -> 1000 mg/day (capped) 16kg -> 1000 mg/day (capped) 17kg -> 1000 mg/day (capped) 18kg -> 1000 mg/day (capped) 19kg -> 1000 mg/day (capped) 20kg -> 1000 mg/day (capped) 21kg -> 1000 mg/day (capped) 22kg -> 1000 mg/day (capped) 23kg -> 1000 mg/day (capped) 24kg -> 1000 mg/day (capped) 25kg -> 1000 mg/day (capped) 26kg -> 1000 mg/day (capped) 27kg -> 1000 mg/day (capped) 28kg -> 1000 mg/day (capped) 29kg -> 1000 mg/day (capped) 30kg -> 1000 mg/day (capped) 31kg -> 1000 mg/day (capped) 32kg -> 1000 mg/day (capped) 33kg -> 1000 mg/day (capped) 34kg -> 1000 mg/day (capped) 35kg -> 1000 mg/day (capped) 36kg -> 1000 mg/day (capped) 37kg -> 1000 mg/day (capped) 38kg -> 1000 mg/day (capped) 39kg -> 1000 mg/day (capped) 40kg -> 1000 mg/day (capped) 41kg -> 1000 mg/day (capped) 42kg -> 1000 mg/day (capped) 43kg -> 1000 mg/day (capped) 44kg -> 1000 mg/day (capped) 45kg -> 1000 mg/day (capped) 46kg -> 1000 mg/day (capped) 47kg -> 1000 mg/day (capped) 48kg -> 1000 mg/day (capped) 49kg -> 1000 mg/day (capped) 50kg -> 1000 mg/day (capped) Source Egyptian National Drug Formulary - Antimicrobial 2023 Why Narrower-spectrum beta-lactam used first-line for mild community-acquired pneumonia without comorbidities, targeting the typical bacterial pathogens responsible for most uncomplicated cases. Caution Switch to broad spectrum if no improvement in 48-72h. Amoxicillin is first-line for mild CAP without comorbidities. Penicillin hypersensitivity is a contraindication. Egypt AMOXYCILLIN 500MG 10 CAPS B.P.2013 ARAB DRUG COMPANY (ADCO) 6.50 EGP (0.65/unit) AMOXICILLIN 500MG 12 CAPS. USP 28 OCTOBER PHARMA 8.10 EGP (0.67/unit) AMOXIL 500MG 12 CAPS. MUP > SMITHKL... 9.00 EGP (0.75/unit) AMOXICID 500 MG 12 CAPS. CID 9.50 EGP (0.79/unit) E-MOX 500 MG 16 CAPS. EIPICO 15.60 EGP (0.97/unit) HICONCIL 500MG 12 CAPS. PHARCO 11.60 EGP (0.97/unit) BIOMOX 500MG 12 CAPS. SEDICO 19.50 EGP (1.62/unit) IBIAMOX 500 MG 12 CAPS. AMOUN 45.00 EGP (3.75/unit) HICILLIN 125MG/5ML SUSP. 80ML EL NASR 3.00 EGP -> ? strength differs, ? different route - not oral solid AMOXIL FORT 250MG/5ML SUSP. 60ML MUP > SMITHKL... 5.50 EGP -> ? strength differs, ? different route - not oral solid 2. CLARITHROMYCIN [2nd line] Adult 500 mg BID x 7 days Peds 15 mg/kg/day [child max 1000 mg] (Divided BID for 7 days) 3kg -> 45 mg/day 4kg -> 60 mg/day 5kg -> 75 mg/day 6kg -> 90 mg/day 7kg -> 105 mg/day 8kg -> 120 mg/day 9kg -> 135 mg/day 10kg -> 150 mg/day 11kg -> 165 mg/day 12kg -> 180 mg/day 13kg -> 195 mg/day 14kg -> 210 mg/day 15kg -> 225 mg/day 16kg -> 240 mg/day 17kg -> 255 mg/day 18kg -> 270 mg/day 19kg -> 285 mg/day 20kg -> 300 mg/day 21kg -> 315 mg/day 22kg -> 330 mg/day 23kg -> 345 mg/day 24kg -> 360 mg/day 25kg -> 375 mg/day 26kg -> 390 mg/day 27kg -> 405 mg/day 28kg -> 420 mg/day 29kg -> 435 mg/day 30kg -> 450 mg/day 31kg -> 465 mg/day 32kg -> 480 mg/day 33kg -> 495 mg/day 34kg -> 510 mg/day 35kg -> 525 mg/day 36kg -> 540 mg/day 37kg -> 555 mg/day 38kg -> 570 mg/day 39kg -> 585 mg/day 40kg -> 600 mg/day 41kg -> 615 mg/day 42kg -> 630 mg/day 43kg -> 645 mg/day 44kg -> 660 mg/day 45kg -> 675 mg/day 46kg -> 690 mg/day 47kg -> 705 mg/day 48kg -> 720 mg/day 49kg -> 735 mg/day 50kg -> 750 mg/day AWaRe WATCH group - carries resistance cost. Egyptian EML 2025. Source Egyptian National Drug Formulary - Antimicrobial 2023 Why Not used alone here. The 2019 ATS/IDSA guidance prefers high-dose amoxicillin as empiric therapy for healthy outpatients 64 and under, and allows a macrolide alone only where local S. pneumoniae macrolide resistance stays under 25%. The same guidance reports resistance often above 30% in the US and above 25% across most of the rest of the world, and no Egyptian figure appears in the cited sources, so that 25% condition cannot be shown to hold here. The Egyptian formulary uses the same cutoff and also defaults to combination therapy. Combine with a beta-lactam, or use levofloxacin instead. Caution Covers atypical pathogens (Mycoplasma, Chlamydia pneumoniae). Use in penicillin allergy or as add-on in moderate CAP. There is a risk of QT prolongation. Egypt KAPIFECTIN 500 MG 14 F.C.TAB. EVA PHARMA 37.00 EGP (2.64/unit) LARITHROCIN 500MG 14 F.C. TABS. GLOBAL NAPI P... 40.00 EGP (2.86/unit) CAPRIVEXIN 500MG S.R. 14 F.C. TAB. HORUS FOR PHARMACEUTICAL... 58.00 EGP (4.14/unit) CLARINOTION XL 500 MG 14 F.C.TABS. RAMEDA > NOTION PHARMA 83.00 EGP (5.93/unit) KLARIMIX 500 MG 14 TAB. SIGMA > OCTOB... 144.00 EGP (10.29/unit) INFECTOCURE 500 MG 14 F.C.TABS. EGPI 156.00 EGP (11.14/unit) KLACID 500 MG 14 F.C.TABS. KAHIRA > ABBO... 257.00 EGP (18.36/unit) KLACID XL 500 MG 14 F.C.TABS. KAHIRA > ABBO... 299.00 EGP (21.36/unit) KLARIMIX 125MG/5ML SUSP. 60ML SIGMA 36.00 EGP -> ? strength differs, ? different route - not oral solid KLARIMIX 250MG/5ML SUSP. 60ML SIGMA 52.00 EGP -> ? strength differs, ? different route - not oral solid 3. LEVOFLOXACIN [2nd line] Adult 750 mg once daily x 5-7 days Peds Contraindicated in children under 18 years (arthropathy risk) AWaRe WATCH group - carries resistance cost. Egyptian EML 2025. Source ATS/IDSA CAP Guideline 2019 Why Respiratory fluoroquinolone with broad activity against both typical and atypical pneumonia pathogens; reserved for patients with comorbidities or those failing first- line beta-lactam therapy, rather than used as initial treatment. Caution Reserve for comorbidities or failure of first-line agents. Levofloxacin can cause QT prolongation and glycemic dysregulation. There is a risk of tendinitis, tendon rupture, and aortic aneurysm. Egypt FLOXABACT 500 MG 10 F.C.TABS.(NOW LEVOFLOXACIN-EVA) EVA PHARMA 40.00 EGP (4.00/unit) LEVOMAGICTAM 500 MG 5 F.C.TABS. MEDIZEN PHARM... 27.00 EGP (5.40/unit) EXACINOP 500 MG 10 F.C.TABS. EL-OBOUR > MA... 65.00 EGP (6.50/unit) ROYAFLOXACIN 500 MG 10 F.C.TABS. MEDIZEN PHARM... 92.00 EGP (9.20/unit) TAVIXINOR 500 MG 5 F.C. TABS. MASH PREMIERE... 64.50 EGP (12.90/unit) BIOWORLD 500 MG 10 F.C. TABS. EGPI > BIOWORLD 133.00 EGP (13.30/unit) TAVANIC 500 MG 5 F.C.TABS. SANOFI 192.00 EGP (38.40/unit) ALFASPECT 500 MG 5 S.F.C.TABS. SPIMACO PHARM... 70.00 EGP 4. DOXYCYCLINE [2nd line] Adult 100 mg twice daily x 5-7 days Peds 2.2 mg/kg/dose [child max 100 mg] (2.2 mg/kg per dose every 12 hours, maximum 100 mg per dose. The formulary restricts use under 8 years to severe or life- threatening infection, or where there is no better alternative - in practice that means a child with CAP gets amoxicillin, not this.) 3kg -> 6.6 mg/dose 4kg -> 8.8 mg/dose 5kg -> 11 mg/dose 6kg -> 13.2 mg/dose 7kg -> 15.4 mg/dose 8kg -> 17.6 mg/dose 9kg -> 19.8 mg/dose 10kg -> 22 mg/dose 11kg -> 24.2 mg/dose 12kg -> 26.4 mg/dose 13kg -> 28.6 mg/dose 14kg -> 30.8 mg/dose 15kg -> 33 mg/dose 16kg -> 35.2 mg/dose 17kg -> 37.4 mg/dose 18kg -> 39.6 mg/dose 19kg -> 41.8 mg/dose 20kg -> 44 mg/dose 21kg -> 46.2 mg/dose 22kg -> 48.4 mg/dose 23kg -> 50.6 mg/dose 24kg -> 52.8 mg/dose 25kg -> 55 mg/dose 26kg -> 57.2 mg/dose 27kg -> 59.4 mg/dose 28kg -> 61.6 mg/dose 29kg -> 63.8 mg/dose 30kg -> 66 mg/dose 31kg -> 68.2 mg/dose 32kg -> 70.4 mg/dose 33kg -> 72.6 mg/dose 34kg -> 74.8 mg/dose 35kg -> 77 mg/dose 36kg -> 79.2 mg/dose 37kg -> 81.4 mg/dose 38kg -> 83.6 mg/dose 39kg -> 85.8 mg/dose 40kg -> 88 mg/dose 41kg -> 90.2 mg/dose 42kg -> 92.4 mg/dose 43kg -> 94.6 mg/dose 44kg -> 96.8 mg/dose 45kg -> 99 mg/dose 46kg -> 100 mg/dose (capped) 47kg -> 100 mg/dose (capped) 48kg -> 100 mg/dose (capped) 49kg -> 100 mg/dose (capped) 50kg -> 100 mg/dose (capped) Choice Sourced preference. The Egyptian EML 2025 lists doxycycline as second choice for mild- to-moderate community-acquired pneumonia, and clarithromycin is demoted for local pneumococcal macrolide resistance above 40%. Source Egyptian National Drug Formulary - Antimicrobial 2023 (doxycycline monograph) Why The Egyptian EML 2025 lists doxycycline as second choice for mild-to-moderate community acquired pneumonia, and it sits in the Access group where clarithromycin and levofloxacin sit in Watch. It covers Mycoplasma, so it is the atypical cover to reach for where a macrolide is unsuitable. Caution Access group - it does not carry the stewardship cost of clarithromycin or levofloxacin, both of which are Watch. Avoid in pregnancy from the second trimester, and in breastfeeding beyond short courses. Swallow with a full glass of water and stay sitting up for 30 minutes - it ulcerates the oesophagus if it lodges. Antacids, iron and calcium block absorption; separate them. Photosensitivity - relevant year-round in Egypt. Egypt FARCODOXIN 100MG 10 CAPS. PHARCO 11.00 EGP (1.10/unit) DOXY M.R.100 MG 10 CAPS. ADWIA 12.00 EGP (1.20/unit) GRANUDOXY 100MG 10 F.C. TAB. GLOBAL NAPI P... 12.00 EGP (1.20/unit) DOXYDOX 100 MG 10 CAPS. EIPICO 23.00 EGP (2.30/unit) DOXYMYCIN 100 MG 10 CAPS. EL NILE. 30.00 EGP (3.00/unit) TABOCINE 100MG 10 CAPS. TABUK PHARMAC... 46.00 EGP (4.60/unit) VIBRAMYCIN 100MG 10 CAPS. PFIZER 65.00 EGP (6.50/unit) IF COMORBIDITY OR RECENT ANTIBIOTICS 5. AMOXICILLIN + CLAVULANIC ACID [1st line] Adult 1 g BID or 875/125 mg BID x 7 days Peds 80-90 mg/kg/day [child max 3000 mg] (Of the amoxicillin component, divided BID (use 14:1 ES-600 formulation to keep clavulanate <10 mg/kg/day)) 3kg -> 240-270 mg/day 4kg -> 320-360 mg/day 5kg -> 400-450 mg/day 6kg -> 480-540 mg/day 7kg -> 560-630 mg/day 8kg -> 640-720 mg/day 9kg -> 720-810 mg/day 10kg -> 800-900 mg/day 11kg -> 880-990 mg/day 12kg -> 960-1080 mg/day 13kg -> 1040-1170 mg/day 14kg -> 1120-1260 mg/day 15kg -> 1200-1350 mg/day 16kg -> 1280-1440 mg/day 17kg -> 1360-1530 mg/day 18kg -> 1440-1620 mg/day 19kg -> 1520-1710 mg/day 20kg -> 1600-1800 mg/day 21kg -> 1680-1890 mg/day 22kg -> 1760-1980 mg/day 23kg -> 1840-2070 mg/day 24kg -> 1920-2160 mg/day 25kg -> 2000-2250 mg/day 26kg -> 2080-2340 mg/day 27kg -> 2160-2430 mg/day 28kg -> 2240-2520 mg/day 29kg -> 2320-2610 mg/day 30kg -> 2400-2700 mg/day 31kg -> 2480-2790 mg/day 32kg -> 2560-2880 mg/day 33kg -> 2640-2970 mg/day 34kg -> 2720-3000 mg/day (upper capped) 35kg -> 2800-3000 mg/day (upper capped) 36kg -> 2880-3000 mg/day (upper capped) 37kg -> 2960-3000 mg/day (upper capped) 38kg -> 3000 mg/day (capped) 39kg -> 3000 mg/day (capped) 40kg -> 3000 mg/day (capped) 41kg -> 3000 mg/day (capped) 42kg -> 3000 mg/day (capped) 43kg -> 3000 mg/day (capped) 44kg -> 3000 mg/day (capped) 45kg -> 3000 mg/day (capped) 46kg -> 3000 mg/day (capped) 47kg -> 3000 mg/day (capped) 48kg -> 3000 mg/day (capped) 49kg -> 3000 mg/day (capped) 50kg -> 3000 mg/day (capped) Source Egyptian National Drug Formulary - Antimicrobial 2023 Why Beta-lactam combined with a beta-lactamase inhibitor, used as first-line empirical outpatient therapy for community-acquired pneumonia; the inhibitor restores activity against beta-lactamase-producing organisms that amoxicillin alone would miss. Caution Take with food to minimize GI adverse effects. This combination is first-line outpatient empirical therapy in Egypt. There is a risk of cholestatic jaundice with prolonged use. Egypt E-MOXCLAV 1G 10 F.C. TAB. EIPICO 14.00 EGP (1.40/unit) JULMENTIN 2X 1GM 15 TAB. JULPHAR 57.50 EGP (3.83/unit) DEXICLAVE 1 GM 10 F.C. TABS. RAMEDA > NOVE... 38.50 EGP (3.85/unit) MACLAVEX 1 GM 14 F.C.TABS. MASH PREMIERE 105.00 EGP (7.50/unit) CLAVIMOX 1 GM 12 F.C.TABS. PHARCO 130.00 EGP (10.83/unit) MEGAMOX 1 GM 14 F.C. TABS. AL JAZEERA PH... 178.00 EGP (12.71/unit) CLAVOCILLIN 1 GM 10 DISPERSIBLE TABS. RAMEDA > ORGANOPHARMA 106.00 EGP AUGMENTIN ADULTS 1GM/125MG 12 PWD. ORAL SUSP. SACHETS GLAXO SMITHKLINE 169.00 EGP LARYNCLAVE 125/31 PD. FOR ORAL SUSP. 70ML MISR > AL ROWAD PHARMACEUTICAL... 8.00 EGP -> ? strength differs, ? different route - not oral solid MEGACLAVOX 156MG/5ML PD. FOR SUSP. 60 ML CID 8.00 EGP -> ? strength differs, ? different route - not oral solid MAIN TREATMENT 6. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY) [1st line] Adult Source Community-Acquired Pneumonia - disease-level clinical article (community-acquired- pneumonia-clinical.txt) Why Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen. Caution RED FLAG - The inpatient admission criterion is a CURB-65 score >= 2. PAIN AND FEVER - give alongside 7. PARACETAMOL [add-on - not a substitute] Adult 1 g three or four times daily, maximum 4 g in 24 hours - while febrile or the chest hurts, usually 3-5 days Peds 15 mg/kg/dose [child max 500 mg] (15 mg/kg per dose every 6 hours. WHO restricts oral paracetamol to children 2 months and over with a fever of 39 C or more who are uncomfortable or distressed by it - do not treat a low fever.) 3kg -> 45 mg/dose 4kg -> 60 mg/dose 5kg -> 75 mg/dose 6kg -> 90 mg/dose 7kg -> 105 mg/dose 8kg -> 120 mg/dose 9kg -> 135 mg/dose 10kg -> 150 mg/dose 11kg -> 165 mg/dose 12kg -> 180 mg/dose 13kg -> 195 mg/dose 14kg -> 210 mg/dose 15kg -> 225 mg/dose 16kg -> 240 mg/dose 17kg -> 255 mg/dose 18kg -> 270 mg/dose 19kg -> 285 mg/dose 20kg -> 300 mg/dose 21kg -> 315 mg/dose 22kg -> 330 mg/dose 23kg -> 345 mg/dose 24kg -> 360 mg/dose 25kg -> 375 mg/dose 26kg -> 390 mg/dose 27kg -> 405 mg/dose 28kg -> 420 mg/dose 29kg -> 435 mg/dose 30kg -> 450 mg/dose 31kg -> 465 mg/dose 32kg -> 480 mg/dose 33kg -> 495 mg/dose 34kg -> 500 mg/dose (capped) 35kg -> 500 mg/dose (capped) 36kg -> 500 mg/dose (capped) 37kg -> 500 mg/dose (capped) 38kg -> 500 mg/dose (capped) 39kg -> 500 mg/dose (capped) 40kg -> 500 mg/dose (capped) 41kg -> 500 mg/dose (capped) 42kg -> 500 mg/dose (capped) 43kg -> 500 mg/dose (capped) 44kg -> 500 mg/dose (capped) 45kg -> 500 mg/dose (capped) 46kg -> 500 mg/dose (capped) 47kg -> 500 mg/dose (capped) 48kg -> 500 mg/dose (capped) 49kg -> 500 mg/dose (capped) 50kg -> 500 mg/dose (capped) Source MSF Essential Drugs 2024 - paracetamol (oral) Why The WHO pocket book instructs paracetamol for a child with pneumonia and a distressing fever of 39 C or more, and gives 15 mg/kg every 6 hours. The adult dose here is from the MSF drug reference. Paracetamol rather than an NSAID is deliberate - see the cautions. Caution WHO treats fever only when it is 39 C or above and distressing the child - a moderate fever in pneumonia does not need suppressing. Paracetamol, not an NSAID, is the antipyretic of choice here: NSAID use in community- acquired pneumonia is associated with delayed diagnosis and with pleuropulmonary complications. Check every other product for paracetamol content before adding it. Reduce the maximum in liver disease or in an adult under 50 kg. 500 mg is the per-dose ceiling used here for a child. 1000 mg is the adult dose and does not belong in a weight calculation - the daily 60 mg/kg limit is the one that binds first in any case. Egypt FEBRIMOL 500 MG 20 TAB. PHARCO 3.50 EGP (0.17/unit) CETAMOL 500 MG 20 TABS. MEMPHIS 8.00 EGP (0.40/unit) PARACETAMOL-MUP 500MG B.P. 20 TABS. MUP 13.00 EGP (0.65/unit) CETAL 500 MG 20 TABS. EIPICO 24.00 EGP (1.20/unit) ARKADOLOW 500 MG 30 F.C. TABS. UTOPIA 42.00 EGP (1.40/unit) PARAMOL 500MG 20 TAB. MISR 38.00 EGP (1.90/unit) ADOL 500MG 24 CAPLETS JULPHAR 32.00 EGP AUGICETAMIDE 500 MG 20 SACHETS AUG PHARMA 50.00 EGP FEBRIMOL ORAL DROPS 20 ML PHARCO 4.00 EGP -> ? strength differs, ? different route - not oral solid THERA-LO 3.2G/100ML ORAL SUSP. 100 ML PHAROPHARMA 5.00 EGP -> ? strength differs, ? different route - not oral solid Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy. ``` --- Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement. [Privacy policy](/privacy)